BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 21332993)

  • 1. Ethidium bromide transport across Mycobacterium smegmatis cell-wall: correlation with antibiotic resistance.
    Rodrigues L; Ramos J; Couto I; Amaral L; Viveiros M
    BMC Microbiol; 2011 Feb; 11():35. PubMed ID: 21332993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis.
    Li XZ; Zhang L; Nikaido H
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2415-23. PubMed ID: 15215089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of the multidrug efflux pump LfrA to innate mycobacterial drug resistance.
    Sander P; De Rossi E; Böddinghaus B; Cantoni R; Branzoni M; Böttger EC; Takiff H; Rodriquez R; Lopez G; Riccardi G
    FEMS Microbiol Lett; 2000 Dec; 193(1):19-23. PubMed ID: 11094273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis.
    Rodrigues L; Wagner D; Viveiros M; Sampaio D; Couto I; Vavra M; Kern WV; Amaral L
    J Antimicrob Chemother; 2008 May; 61(5):1076-82. PubMed ID: 18310137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug resistance of a porin deletion mutant of Mycobacterium smegmatis.
    Stephan J; Mailaender C; Etienne G; Daffé M; Niederweis M
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4163-70. PubMed ID: 15504836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of porins for uptake of antibiotics by Mycobacterium smegmatis.
    Danilchanka O; Pavlenok M; Niederweis M
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3127-34. PubMed ID: 18559650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis.
    Lechner D; Gibbons S; Bucar F
    J Antimicrob Chemother; 2008 Aug; 62(2):345-8. PubMed ID: 18430720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Mycobacterial Efflux Pump EfpA Can Induce High Drug Tolerance to Many Antituberculosis Drugs, Including Moxifloxacin, in Mycobacterium smegmatis.
    Rai D; Mehra S
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0026221. PubMed ID: 34424047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The growth rate of Mycobacterium smegmatis depends on sufficient porin-mediated influx of nutrients.
    Stephan J; Bender J; Wolschendorf F; Hoffmann C; Roth E; Mailänder C; Engelhardt H; Niederweis M
    Mol Microbiol; 2005 Nov; 58(3):714-30. PubMed ID: 16238622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis.
    Buroni S; Manina G; Guglierame P; Pasca MR; Riccardi G; De Rossi E
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4044-52. PubMed ID: 17043130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PNA-mediated efflux inhibition as a therapeutic strategy towards overcoming drug resistance in Mycobacterium smegmatis.
    Ghosh S; Cotta KB; Hande AA; Fernandes M; Mehra S
    Microb Pathog; 2021 Feb; 151():104737. PubMed ID: 33453316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farnesol, a potential efflux pump inhibitor in Mycobacterium smegmatis.
    Jin J; Zhang JY; Guo N; Sheng H; Li L; Liang JC; Wang XL; Li Y; Liu MY; Wu XP; Yu L
    Molecules; 2010 Oct; 15(11):7750-62. PubMed ID: 21042264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flavonoids as Novel Efflux Pump Inhibitors and Antimicrobials Against Both Environmental and Pathogenic Intracellular Mycobacterial Species.
    Solnier J; Martin L; Bhakta S; Bucar F
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32046221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide.
    Couto I; Costa SS; Viveiros M; Martins M; Amaral L
    J Antimicrob Chemother; 2008 Sep; 62(3):504-13. PubMed ID: 18511413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis.
    Danilchanka O; Mailaender C; Niederweis M
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2503-11. PubMed ID: 18458127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porins limit the intracellular persistence of Mycobacterium smegmatis.
    Sharbati-Tehrani S; Stephan J; Holland G; Appel B; Niederweis M; Lewin A
    Microbiology (Reading); 2005 Jul; 151(Pt 7):2403-2410. PubMed ID: 16000730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MspA provides the main hydrophilic pathway through the cell wall of Mycobacterium smegmatis.
    Stahl C; Kubetzko S; Kaps I; Seeber S; Engelhardt H; Niederweis M
    Mol Microbiol; 2001 Apr; 40(2):451-64. PubMed ID: 11309127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The plant alkaloid piperine as a potential inhibitor of ethidium bromide efflux in Mycobacterium smegmatis.
    Jin J; Zhang J; Guo N; Feng H; Li L; Liang J; Sun K; Wu X; Wang X; Liu M; Deng X; Yu L
    J Med Microbiol; 2011 Feb; 60(Pt 2):223-229. PubMed ID: 21051548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efflux pump inhibition by 11H-pyrido[2,1-b]quinazolin-11-one analogues in mycobacteria.
    Sen T; Neog K; Sarma S; Manna P; Deka Boruah HP; Gogoi P; Singh AK
    Bioorg Med Chem; 2018 Sep; 26(17):4942-4951. PubMed ID: 30190182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyacrylic acid-coated iron oxide nanoparticles for targeting drug resistance in mycobacteria.
    Padwal P; Bandyopadhyaya R; Mehra S
    Langmuir; 2014 Dec; 30(50):15266-76. PubMed ID: 25375643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.